CoChat

Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights

Stein, Ricardo, Ferrari, Filipe, Scolari, Fernando · 2019 · Current Cardiology Reports

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Abstract

Purpose of review The cardiovascular (CV) risk related to lipid disorders is well established and is based on a robust body of evidence from well-designed randomized clinical trials, as well as prospective observational studies. In the last two decades, significant advances have been made in understanding the genetic basis of dyslipidemias. The present review is intended as a comprehensive discussion of current knowledge about the genetics and pathophysiology of disorders that predispose to dyslipidemia. We also focus on issues related to statins and the proprotein convertase subtilisin/kexin type 9 (PCSK9) and some of its polymorphisms, as well as new cholesterol-lowering medications, including PCSK9 inhibitors. Recent finding Cholesterol is essential for the proper functioning of several body systems. However, dyslipidemia-especially elevated low-density lipoprotein (LDL-c) and triglyceride levels, as well as reduced lipoprotein lipase activity-is associated with an increased risk of coronary artery disease (CAD). High-density lipoprotein (HDL-c), however, seems to play a role as a risk marker rather than as a causal factor of the disease, as suggested by Mendelian randomization studies. Several polymorphisms in the lipoprotein lipase locus have been described and are associated with variations in the activity of this enzyme, producing high concentrations of triglycerides and increased risk of CAD. Dyslipidemia, especially increased LDL-c and triglyceride levels, continues…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11886-019-1161-5

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 110 references

Cited by

See all 83

Metadata

Authors
Stein, R., Ferrari, F., & Scolari, F.
Affiliations
Universidade Federal do Rio Grande do Sul (BR)
Corresponding author
Stein, Ricardo
Venue
Current Cardiology Reports
Published
2019-06-21
Volume
21
Issue
8
Pages
68-68
ISSN
  • 1523-3782 (ISSN-L)
  • 1534-3170
OpenAlex
W2951317411
Cited by
83
References
109
Citations by year
2026: 5 · 2025: 7 · 2024: 16 · 2023: 17 · 2022: 12 · 2021: 13 · 2020: 11 · 2019: 1
FWCI
1.91
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Current Cardiology Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
dyslipidemia, cardiovascular disease, PCSK9, PCSK9 inhibitors, statins, LDL cholesterol, triglycerides, HDL cholesterol, coronary artery disease, primary prevention, Mendelian randomization
MeSH terms
Proprotein Convertase 9, PCSK9 Inhibitors, Cardiovascular Diseases, Humans, Lipoproteins, LDL, Cholesterol, LDL, Mutation, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dyslipidemias, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights. https://app.cochat.ai/papers/10.1007/s11886-019-1161-5
The paper
Stein, R., Ferrari, F., & Scolari, F. (2019). Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights. Current Cardiology Reports. https://doi.org/10.1007/s11886-019-1161-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.